Health Telemonitoring

OTHER7 trials

Sponsors

M.D. Anderson Cancer Center, Fred Hutchinson Cancer Center, Fox Chase Cancer Center, ECOG-ACRIN Cancer Research Group, Mayo Clinic

Conditions

Acute Myeloid LeukemiaAnatomic Stage IV Breast Cancer AJCC v8Breast CarcinomaHER2-Negative Breast CarcinomaHematologic MalignanciesHematopoietic and Lymphatic System NeoplasmHematopoietic and Lymphoid System NeoplasmHormone Receptor-Positive Breast Carcinoma

Phase 3

Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy

RecruitingNCT07186192

City of Hope Medical CenterHematologic Malignancies

Start: 2026-01-14End: 2029-03-29Target: 190Updated: 2026-01-28

Unknown Phase

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients

RecruitingNCT01365169

M.D. Anderson Cancer CenterMalignant Head and Neck Neoplasm, Malignant Neoplasm, Metastatic Malignant Neoplasm in the Neck +45

Start: 2011-05-25End: 2027-06-30Target: 590Updated: 2026-01-07

Telemonitoring Device in Managing Outpatient Care of Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia After Intensive Chemotherapy

TerminatedNCT02226497

Fred Hutchinson Cancer CenterAcute Myeloid Leukemia, Myelodysplastic Syndrome

Start: 2015-01-09End: 2018-08-30Updated: 2020-01-10

SMART Project in Preventing Skin Cancer

CompletedNCT03177057

Fox Chase Cancer CenterSkin Carcinoma

Start: 2013-04-23End: 2014-12-31Updated: 2018-08-01

Mobile Health for Adherence in Breast Cancer Patients

RecruitingNCT06112613

ECOG-ACRIN Cancer Research GroupAnatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, HER2-Negative Breast Carcinoma +1

Start: 2024-01-26End: 2027-07-31Target: 410Updated: 2026-04-03

A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors (ASCENT)

RecruitingNCT06198010

Mayo ClinicHematopoietic and Lymphatic System Neoplasm, Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm

Start: 2024-02-07End: 2027-08-31Target: 660Updated: 2025-12-01

Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial

RecruitingNCT07302230

University of WashingtonLocalized Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8 +1

Start: 2026-03-11End: 2027-05-31Target: 100Updated: 2026-03-13

Related Papers

Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CD.

UNC Libraries2026-03-14

Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CD.

2025-11-18